Clopidogrel (hydrogen sulfate)
Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively[1]. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation[2].Clopidogrel hydrogen sulfate also is an orally active P2Y (12) inhibitor[5].
Product Specifications
CAS Number
[120202-66-6]
Product Name Alternative
(S) - (+) -Clopidogrel bisulfate; (S) - (+) -Clopidogrel hydrogen sulfate
UNSPSC
12352005
Hazard Statement
H314, H318, H401, H411
Target
Cytochrome P450; P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Clopidogrel-hydrogen-sulfate.html
Purity
99.88
Solubility
DMSO : 200 mg/mL (ultrasonic) |H2O : 16.67 mg/mL (ultrasonic)
Smiles
ClC1=C([C@@H](C(OC)=O)N2CCC3=C(C=CS3)C2)C=CC=C1.O=S(O)(O)=O
Molecular Formula
C16H18ClNO6S2
Molecular Weight
419.90
Precautions
H314, H318, H401, H411
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
CYP2; P2Y12 Receptor
Citation 01
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items